Accessibility Menu
Little Green Pharma logo

Little Green Pharma(ASX) LGP

This security has been delisted. This page is retained for historical reference.

Little Green Pharma last closing stock price
MetricPriceDate
Last closeAUD 0.082026-08-13
Little Green Pharma stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.32%AUD 0.082026-08-06
1 month+5.63%AUD 0.072026-07-14
3 month-22.68%AUD 0.102026-05-15
Year to date-40%AUD 0.132025-12-31
1 year-31.82%AUD 0.112025-08-13
3 year-61.54%AUD 0.202023-08-14
5 year-89.86%AUD 0.742021-08-13
Since inception-75.71%AUD 0.352020-02-20

LGP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

LGP Financials

Key Financial Metrics (TTM)

Gross Margin

27.65%

Operating Margin

-4.62%

Net Income Margin

-3.32%

Return on Equity

-1.67%

Return on Capital

-2.23%

Return on Assets

-1.50%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

A$22.80M

Operating Income

-A$2.37M

EBITDA

A$3.66M

Operating Cash Flow

-A$2.44M

Capital Expenditure

-A$928.00K

Free Cash Flow

-A$3.37M

Cash & ST Invst.

A$1.42M

Total Debt

A$4.69M

Little Green Pharma Performance Analysis

Little Green Pharma annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31AUD 19,859,12341.4%
20242024-03-31AUD 25,632,00029.1%
20252025-03-31AUD 36,824,00043.7%
20262026-03-31AUD 42,425,00015.2%
Little Green Pharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31N/A
Q42025-03-3199.8%
Q22025-09-30N/A
Q42026-03-31N/A
Little Green Pharma annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31AUD -0.03-66.9%
20242024-03-31AUD -0.03-20.5%
20252025-03-31AUD 0.01N/A
20262026-03-31AUD -0.00N/A
Little Green Pharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-12-31N/A
Q42025-03-31N/A
Q22025-09-30N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$23.24M

+85.3%

Gross Profit

A$6.70M

+93.2%

Gross Margin

28.84%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

94

N/A

Net Income

-A$482.00K

+76.8%

EBITDA

A$1.30M

+141.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$1.42M

-77.1%

Total Debt

A$4.69M

-18.6%

Accounts Receivable

A$6.08M

-20.3%

Inventory

A$16.36M

+34.8%

Long Term Debt

A$3.43M

+12.7%

Short Term Debt

A$1.26M

-53.6%

Return on Assets

-1.50%

N/A

Return on Invested Capital

-2.26%

N/A

Free Cash Flow

-A$606.00K

+73.8%

Operating Cash Flow

-A$191.00K

+89.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VIT.AXVitura Health Limited
A$0.02+0.00%
NXS.AXNext Science Limited
A$0.15+0.00%
IIQ.AXINOVIQ Ltd
A$0.20+2.63%
EYE.AXNova Eye Medical Limited
A$0.15-3.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.